Your browser doesn't support javascript.
loading
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs.
Takamatsu, Hiroyuki; Matsuda, Tomohiro; Mizuno, Shohei; Takahashi, Tsutomu; Fuchida, Shin-Ichi; Hanamura, Ichiro; Kataoka, Keisuke; Tsukada, Nobuhiro; Matsumoto, Morio; Hangaishi, Akira; Doki, Noriko; Uchida, Naoyuki; Sawa, Masashi; Maruyama, Yumiko; Kurahashi, Shingo; Nagafuji, Koji; Harazaki, Yoriko; Kako, Shinichi; Iida, Shinsuke; Ichinohe, Tatsuo; Kanda, Yoshinobu; Atsuta, Yoshiko; Sunami, Kazutaka.
  • Takamatsu H; Department of Hematology, Kanazawa University, Kanazawa. takamaz@staff.kanazawa-u.ac.jp.
  • Matsuda T; Division of International Health Policy Research, National Cancer Center Institute for Cancer Control, Tokyo.
  • Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute.
  • Takahashi T; Department of Hematology, Shimane University Hospital, Izumo.
  • Fuchida SI; Department of Hematology, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, Kyoto.
  • Hanamura I; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute.
  • Kataoka K; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo.
  • Tsukada N; Division of Hematology, Japanese Red Cross Medical Center, Tokyo.
  • Matsumoto M; Department of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa.
  • Hangaishi A; Department of Hematology, National Center for Global Health and Medicine, Tokyo.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL, Tokyo.
  • Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo.
  • Maruyama Y; Department of Hematology, University of Tsukuba Hospital, Tsukuba.
  • Kurahashi S; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi.
  • Nagafuji K; Division of Hematology and Oncology, Department of Medicine, Kurume University Hospital, Kurume.
  • Harazaki Y; Division of Hematology, Miyagi Cancer Center, Natori.
  • Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama.
  • Iida S; Division of Hematology and Oncology, Nagoya City University Hospital, Nagoya.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University.
  • Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke.
  • Atsuta Y; Aichi Medical University School of Medicine / Department of Registry Science for Transplant and Cellular Therapy, Nagakute.
  • Sunami K; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama.
Haematologica ; 108(12): 3399-3408, 2023 12 01.
Article en En | MEDLINE | ID: mdl-37470160
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article